Duluth MN 前列腺癌临床试验
7项针对 前列腺癌的研究正在 Duluth及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
招募中2 期
- Essentia Health Cancer Center, Duluth
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Essentia Health Cancer Center, Duluth
- Essentia Health Saint Mary's Medical Center, Duluth
- Miller-Dwan Hospital, Duluth
- 以及另外 2 项
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
招募中2 期
- Essentia Health Cancer Center, Duluth
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
招募中3 期
- Essentia Health Cancer Center, Duluth
- Essentia Health Saint Mary's Medical Center, Duluth
- Miller-Dwan Hospital, Duluth
- 以及另外 2 项
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- Essentia Health Cancer Center, Duluth
- Essentia Health Saint Mary's Medical Center, Duluth
- Miller-Dwan Hospital, Duluth
- 以及另外 1 项
Integrated Cancer Repository for Cancer Research
招募中观察性研究欢迎健康志愿者
- Essentia Health - Duluth Clinic, Duluth
- St. Luke's Hospital of Duluth, Duluth
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Duluth
其他城市的 前列腺癌试验
- New York City, NY101 项研究
- Houston, TX73 项研究
- Los Angeles, CA64 项研究
- Boston, MA56 项研究
- Seattle, WA45 项研究
- St. Louis, MO45 项研究
- Chicago, IL45 项研究
- Baltimore, MD45 项研究
- San Francisco, CA44 项研究
- Philadelphia, PA41 项研究
- Nashville, TN40 项研究
- Washington, DC39 项研究
Duluth的其他研究
- 非小细胞肺癌14 项研究
- 肺癌11 项研究
- 乳腺癌7 项研究
- 急性髓系白血病6 项研究
- 膀胱癌6 项研究
- 结肠癌6 项研究
- 卵巢癌5 项研究
- 慢性淋巴细胞白血病5 项研究
- 子宫内膜癌5 项研究
- 胃癌5 项研究
- 直肠癌5 项研究
- 食管癌5 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。